RBP4 and metabolic dysfunction-associated steatotic liver disease: Elevated RBP4 serves as a potential marker for early NAFLD diagnosis [78], and total bilirubin is pivotal in multiple liver disease models, including as a predictor for advanced fibrosis and cholangiocarcinoma [79–84].